RE:Mergers & Acquisitions: Canopy buyout??They're not even in the top 10. Peter Facchini made their dependence on the raw poppy obsolete.
starsearcher40 wrote: Many of us here have been around this sector for a ocuple of years now, but we do have to remind ourselves that this is a sector that is still truly in its infancy. And with that, there will be a very natural cycle of mergers and acquisitions within the industry. We've already seen some of that with Canopy buying up other LP.'s.
I think it's worth entertaining Mergers and Aquisitions ABOVE Canopy though. By this I mean not who Canopy might buy up, but rather who may buy Canopy itself. Now we can argue to the cows come home that this would never happen, or that Bruce wouldn't want this.....on and on. But at the end of the day, it's all just business, and this, whether we want it or like it, IS a very real possibility.
I'm really intrigued by the partnership with Alcaliber SA, one of THE biggest pharmacuticals in the world, currently producing 27% of the word's ENTIRE morphine supply. This isn't just a massive pharmacutical kicking tires around the mj world. This is a massive pharmacutical now actively getting involved and now fully partnered with Canopy.
How long do you think before offers of buyouts come in? Yes, when that happens, we'll all make a massive fortune on the stock. Yes, I'll be more than a little sad about it too (wealthy, but sad), because I absolutely love this company, it's story, and its development. But again, this IS business., and we are now entering a phase where you can't help but consider that the "picking is ripe" for major pharmas and possiblly big tobacco to become fully positioned through acquisitions. Particularly with pharmas, it's what they do.
Is Canopy at that point now where it may be actively pursued? Personally, I think it fully is. It has established itself as the runaway leader, and dominiant force. At the same time, it hasn't yet grown into the behemoth that we all know it will soon be. Given this, it's at a "sweet spot" for consideration in the pharma acquisitions.
So there's my non-emotional take on things. Remember, at the end of the day, it's just business. The nice thing with Canopy is that no matter which way it goes (alone or bought), it's going to be a stunningly massive gain for shareholders.